BioDlink Biopharm has obtained GMP certification from Argentina, enhancing its global presence and commitment to oncological therapies with Pusintin® injection.

Global Milestone: GMP certification from Argentina, marking a key step in its global expansion and regulatory recognition. Scalable, Trustworthy Solutions: With advanced manufacturing capabilities, BioDlink deliver Pusintin® (bevacizumab) injection that are not only consistent and...